Biosecurity : the socio-politics of invasive species and infectious diseases / / edited by Andrew Dobson, Kezia Barker and Sarah Taylor |
Edizione | [1st ed.] |
Pubbl/distr/stampa | London ; ; New York : , : Routledge, , 2013 |
Descrizione fisica | 1 online resource (256 p.) |
Disciplina | 363.1 |
Altri autori (Persone) |
BarkerKezia
DobsonAndrew TaylorSarah L |
Soggetto topico |
Biosecurity - Political aspects
Nonindigenous pests - Control - Political aspects Communicable diseases - Prevention - Political aspects |
ISBN |
0-415-53477-1
0-203-11311-X 1-136-28550-4 1-136-28551-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover ; Half Title ; Title Page ; Copyright Page ; Dedication ; Table of Contents ; Notes on contributors ; Acknowledgements ; Part I: Framing biosecurity ; 1. Introduction: interrogating bio-insecurities; Introduction to biosecurity: defining biosecurity threats; The securitization paradigm
Description of 'sites' of biosecurity practice The pre-border domain; Passenger and goods border control; Post-border: surveillance; Post-border: incursion response and pest management; Introduction to this book; References; 2. A world in peril? The case for containment; Introduction; Ecological impacts; Time lags and invasional meltdown; Economic impacts; Human and animal health impacts; Predicting introduction impacts Can containment be effective?References; 3. Power over life: biosecurity as biopolitics; Introduction; Governing unruly assemblages; Proliferating life: biosecurity's ontologies; Fielding the incipient event: making biological risk calculable; Biosecurity as biopolitics; Notes; References; Part II: Implementing biosecurity; 4. Governing biosecurity; Introduction; Policy and regulatory frameworks; Surveillance and risk; Paying for biosecurity; Engaging beyond producers; Conclusion; References; 5. Legal frameworks for biosecurity; Introduction; Why is legislation important for biosecurity? Pre-entryPoint-of-entry; Post-entry; The development of legal controls for agriculture and public health; The international legal framework for biosecurity; International standard-setting bodies; The World Trade Organization; Environmental protection and multilateral environmental agreements; Invasive species; Implementing domestic legal frameworks for biosecurity; Conclusion; Notes; References; 6. Biosecurity: whose knowledge counts?; Introduction: reframing animal disease; Biosecurity and the emergence of veterinary expertise; Contesting biosecurity expertise Broadening the evidence base: the role of interdisciplinarityConclusion; References; 7. Biosecurity management practices: determining and delivering a response; Prevention; Risk profiling and risk management; Quarantine and surveillance; Eradication and pest management; Weighing the costs, benefits, risks and the capacity to respond; From eradication to pest management; Cost sharing and resource allocation; Responsibility sharing: public vs private; Conclusion; Notes; References; Part III: Biosecurity and geopolitics 8. A neoliberal biosecurity? The WTO, free trade and the governance of plant health |
Record Nr. | UNINA-9910810726003321 |
London ; ; New York : , : Routledge, , 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Bioterrorism preparedness [[electronic resource] ] : medicine - public health - policy / / edited by Nancy Khardori |
Autore | Khardori Nancy |
Pubbl/distr/stampa | Weinheim, : Wiley-VCH |
Descrizione fisica | 1 online resource (277 p.) |
Disciplina | 363.1 |
Altri autori (Persone) | KhardoriNancy |
Soggetto topico |
Bioterrorism
Bioterrorism - Health aspects Bioterrorism - Prevention - International cooperation |
ISBN |
1-280-72344-0
9786610723447 3-527-60813-3 3-527-60773-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Bioterrorism Preparedness; List of Contents; Preface; List of Authors; 1 Potential Agents of Bioterrorism: Historical Perspective and an Overview; 1.1 Historical Perspective - How We Got Here; 1.2 Development of Modern Biological Weapons; 1.3 Biological Weapons Systems; 1.4 Potential Bioterrorism Agents - Categorization and Prioritization; 1.5 Category B - Bacterial/Rickettsial Agents of Bioterrorism; 1.5.1 Brucellosis; 1.5.2 Glanders and Melioidosis; 1.5.3 Psittacosis; 1.5.4 Q Fever; 1.5.5 Typhus Fever; 1.5.6 Food and Water Safety Threats; 1.6 Category B - Viral Agents of Bioterrorism
1.6.1 Alphavirus Encephalomyelitis1.7 Category B - Biological Toxins for Bioterrorism; 1.7.1 Enterotoxin B; 1.7.2 Epsilon (Alpha Toxin); 1.7.3 Ricin Toxin; 1.7.4 T-2 Mycotoxins; 1.8 Other Toxins With Potential for Bioterrorism; 1.8.1 Nipah and Hendra Viruses; 1.9 Emerging Threats and Potential Agents of Bioterrorism; 1.9.1 Pandemic Influenza - Human and Avian Influenza Viruses; 1.9.2 Severe Acute Respiratory Syndrome (SARS) - SARS-associated Coronavirus (SARS-COV); 1.9.3 Other Emerging Threats; 2 Bioterrorism Preparedness: Historical Perspective and an Overview; 2.1 Introduction 2.2 International Biodefense Actions in the Nineteenth Century and Their Impact2.3 Civilian Biodefense - The Obstacles; 2.4 Bioterrorism Preparedness - The Rationale; 2.5 Bioterrorism Preparedness - The Avenues; 2.5.1 Public Health Laws; 2.5.2 Public Health System Preparedness; 2.5.3 Political Preparedness; 2.5.4 Bioterrorism Preparedness - Global Avenues; 3 Care of Children in the Event of Bioterrorism; 3.1 Introduction; 3.2 Increased Vulnerability of Children; 3.2.1 Anatomic and Physiological Features Placing Children at Increased Risk of Vulnerability 3.2.2 Developmental Factors Involved in Increased Vulnerability of Children3.2.3 Delayed Diagnosis in Children; 3.2.4 Unique Management Needs of Children; 3.2.5 Decontamination Showers; 3.2.6 Doses of Medication; 3.2.7 Size of Equipment; 3.2.8 Training of Healthcare Workers to Meet the Special Needs of Children; 3.2.9 Communication with Children about Disasters; 3. 2. 10 Communication with Adolescents about Disasters; 3.3 Categories of Biological Agents and Toxins; 3.3.1 Smallpox (Variola); 3.3.2 Anthrax; 3.3.3 Botulism; 3.3.4 Plague; 3.3.5 Tularemia 4 Smallpox: Virology, Clinical Presentation, and Prevention4.1 Introduction; 4.2 History; 4.3 Virology; 4.4 Clinical Features and Classification; 4.4.1 Rash and Prognosis; 4.5 The Stages of Smallpox; 4.5.1 Incubation Period; 4.5.2 Pre-eruptive Stage; 4.5.3 Eruptive Stage; 4.6 Ordinary Type; 4.6.1 Death; 4.7 Modified-type; 4.7.1 Variola Sine Eruptione and Subclinical Infection; 4.8 Flat-type; 4.9 Hemorrhagic-type; 4.10 Early Hemorrhagic-type; 4.11 Late Hemorrhagic-type; 4.12 Complications; 4.12.1 Skin; 4.12.1 Respiratory; 4.12.1 Gastrointestinal; 4.12.1 Neurological; 4.12.1 Ophthalmic 4.12.1 Osteo-articular |
Record Nr. | UNINA-9910830482203321 |
Khardori Nancy | ||
Weinheim, : Wiley-VCH | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Bioterrorism preparedness : medicine - public health - policy / / edited by Nancy Khardori |
Autore | Khardori Nancy |
Pubbl/distr/stampa | Weinheim, : Wiley-VCH |
Descrizione fisica | 1 online resource (277 p.) |
Disciplina | 363.1 |
Soggetto topico |
Bioterrorism
Bioterrorism - Health aspects Bioterrorism - Prevention - International cooperation |
ISBN |
1-280-72344-0
9786610723447 3-527-60813-3 3-527-60773-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Bioterrorism Preparedness; List of Contents; Preface; List of Authors; 1 Potential Agents of Bioterrorism: Historical Perspective and an Overview; 1.1 Historical Perspective - How We Got Here; 1.2 Development of Modern Biological Weapons; 1.3 Biological Weapons Systems; 1.4 Potential Bioterrorism Agents - Categorization and Prioritization; 1.5 Category B - Bacterial/Rickettsial Agents of Bioterrorism; 1.5.1 Brucellosis; 1.5.2 Glanders and Melioidosis; 1.5.3 Psittacosis; 1.5.4 Q Fever; 1.5.5 Typhus Fever; 1.5.6 Food and Water Safety Threats; 1.6 Category B - Viral Agents of Bioterrorism
1.6.1 Alphavirus Encephalomyelitis1.7 Category B - Biological Toxins for Bioterrorism; 1.7.1 Enterotoxin B; 1.7.2 Epsilon (Alpha Toxin); 1.7.3 Ricin Toxin; 1.7.4 T-2 Mycotoxins; 1.8 Other Toxins With Potential for Bioterrorism; 1.8.1 Nipah and Hendra Viruses; 1.9 Emerging Threats and Potential Agents of Bioterrorism; 1.9.1 Pandemic Influenza - Human and Avian Influenza Viruses; 1.9.2 Severe Acute Respiratory Syndrome (SARS) - SARS-associated Coronavirus (SARS-COV); 1.9.3 Other Emerging Threats; 2 Bioterrorism Preparedness: Historical Perspective and an Overview; 2.1 Introduction 2.2 International Biodefense Actions in the Nineteenth Century and Their Impact2.3 Civilian Biodefense - The Obstacles; 2.4 Bioterrorism Preparedness - The Rationale; 2.5 Bioterrorism Preparedness - The Avenues; 2.5.1 Public Health Laws; 2.5.2 Public Health System Preparedness; 2.5.3 Political Preparedness; 2.5.4 Bioterrorism Preparedness - Global Avenues; 3 Care of Children in the Event of Bioterrorism; 3.1 Introduction; 3.2 Increased Vulnerability of Children; 3.2.1 Anatomic and Physiological Features Placing Children at Increased Risk of Vulnerability 3.2.2 Developmental Factors Involved in Increased Vulnerability of Children3.2.3 Delayed Diagnosis in Children; 3.2.4 Unique Management Needs of Children; 3.2.5 Decontamination Showers; 3.2.6 Doses of Medication; 3.2.7 Size of Equipment; 3.2.8 Training of Healthcare Workers to Meet the Special Needs of Children; 3.2.9 Communication with Children about Disasters; 3. 2. 10 Communication with Adolescents about Disasters; 3.3 Categories of Biological Agents and Toxins; 3.3.1 Smallpox (Variola); 3.3.2 Anthrax; 3.3.3 Botulism; 3.3.4 Plague; 3.3.5 Tularemia 4 Smallpox: Virology, Clinical Presentation, and Prevention4.1 Introduction; 4.2 History; 4.3 Virology; 4.4 Clinical Features and Classification; 4.4.1 Rash and Prognosis; 4.5 The Stages of Smallpox; 4.5.1 Incubation Period; 4.5.2 Pre-eruptive Stage; 4.5.3 Eruptive Stage; 4.6 Ordinary Type; 4.6.1 Death; 4.7 Modified-type; 4.7.1 Variola Sine Eruptione and Subclinical Infection; 4.8 Flat-type; 4.9 Hemorrhagic-type; 4.10 Early Hemorrhagic-type; 4.11 Late Hemorrhagic-type; 4.12 Complications; 4.12.1 Skin; 4.12.1 Respiratory; 4.12.1 Gastrointestinal; 4.12.1 Neurological; 4.12.1 Ophthalmic 4.12.1 Osteo-articular |
Record Nr. | UNINA-9910876910203321 |
Khardori Nancy | ||
Weinheim, : Wiley-VCH | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
CE marking, product standards and world trade / David Hanson |
Autore | HANSON, David |
Pubbl/distr/stampa | Cheltenham [etc.] : Edward Elgar, 2005 |
Descrizione fisica | XIII, 236 p. ; 24 cm. |
Disciplina | 363.1 |
Soggetto topico | Tecnologia - Standardizzazione |
ISBN | 1-84376-773-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-990000138760203316 |
HANSON, David | ||
Cheltenham [etc.] : Edward Elgar, 2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop summary / / Denise Caruso, Rebecca A. English, Anne B. Claiborne |
Autore | Caruso Denise |
Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2014 |
Descrizione fisica | 1 online resource (150 p.) |
Disciplina | 363.1 |
Soggetto topico |
Risk assessment
Communication |
Soggetto genere / forma | Electronic books. |
ISBN | 0-309-31001-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Boxes, Figures, and Table""; ""Acronyms""; ""1 Introduction""; ""2 Identifying and Characterizing Uncertainty""; ""3 The Regulators Challenge""; ""4 Basic Methodologies and Applications for Understanding and Evaluating Uncertainty""; ""5 Communicating Uncertainty""; ""6 Final Reflections on Ways to Characterize and Communicate Uncertainty""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: FDA Case Studies""; ""Appendix C: Bibliography""; ""Appendix D: Participant Biographies"" |
Record Nr. | UNINA-9910460617803321 |
Caruso Denise | ||
Washington, District of Columbia : , : The National Academies Press, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop summary / / Denise Caruso, Rebecca A. English, Anne B. Claiborne |
Autore | Caruso Denise |
Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2014 |
Descrizione fisica | 1 online resource (150 p.) |
Disciplina | 363.1 |
Soggetto topico |
Risk assessment
Communication |
ISBN |
0-309-31003-2
0-309-31001-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Boxes, Figures, and Table""; ""Acronyms""; ""1 Introduction""; ""2 Identifying and Characterizing Uncertainty""; ""3 The Regulators Challenge""; ""4 Basic Methodologies and Applications for Understanding and Evaluating Uncertainty""; ""5 Communicating Uncertainty""; ""6 Final Reflections on Ways to Characterize and Communicate Uncertainty""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: FDA Case Studies""; ""Appendix C: Bibliography""; ""Appendix D: Participant Biographies"" |
Record Nr. | UNINA-9910787440803321 |
Caruso Denise | ||
Washington, District of Columbia : , : The National Academies Press, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop summary / / Denise Caruso, Rebecca A. English, Anne B. Claiborne |
Autore | Caruso Denise |
Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2014 |
Descrizione fisica | 1 online resource (150 p.) |
Disciplina | 363.1 |
Soggetto topico |
Risk assessment
Communication |
ISBN |
0-309-31003-2
0-309-31001-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Boxes, Figures, and Table""; ""Acronyms""; ""1 Introduction""; ""2 Identifying and Characterizing Uncertainty""; ""3 The Regulators Challenge""; ""4 Basic Methodologies and Applications for Understanding and Evaluating Uncertainty""; ""5 Communicating Uncertainty""; ""6 Final Reflections on Ways to Characterize and Communicate Uncertainty""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: FDA Case Studies""; ""Appendix C: Bibliography""; ""Appendix D: Participant Biographies"" |
Record Nr. | UNINA-9910819643103321 |
Caruso Denise | ||
Washington, District of Columbia : , : The National Academies Press, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Characterizing uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop in brief / / Institute of Medicine (U.S.) |
Pubbl/distr/stampa | [Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 |
Descrizione fisica | 1 online resource (8 p.) |
Disciplina | 363.1 |
Collana | Workshop in Brief |
Soggetto topico |
Risk assessment
Communication |
Soggetto genere / forma | Electronic books. |
ISBN | 0-309-36840-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products-Workshop in Brief"" |
Record Nr. | UNINA-9910466421203321 |
[Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Characterizing uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop in brief / / Institute of Medicine (U.S.) |
Pubbl/distr/stampa | [Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 |
Descrizione fisica | 1 online resource (8 p.) |
Disciplina | 363.1 |
Collana | Workshop in Brief |
Soggetto topico |
Risk assessment
Communication |
ISBN | 0-309-36840-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products-Workshop in Brief"" |
Record Nr. | UNINA-9910796464303321 |
[Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Characterizing uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop in brief / / Institute of Medicine (U.S.) |
Pubbl/distr/stampa | [Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 |
Descrizione fisica | 1 online resource (8 p.) |
Disciplina | 363.1 |
Collana | Workshop in Brief |
Soggetto topico |
Risk assessment
Communication |
ISBN | 0-309-36840-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ""Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products-Workshop in Brief"" |
Record Nr. | UNINA-9910810901403321 |
[Washington, District of Columbia] : , : Institute of Medicine of the National Academies, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|